This is a clinical study to investigate the pharmacokinetics/pharmacodynamics and tolerability of DA-1229(Evogliptin) tabletin renal impaired patients.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Masking
NONE
Enrollment
30
Clinical Trial Center, Seoul National University Hospital
Seoul, South Korea
Area Under Curve(AUC) last
Time frame: Pre-dose, 1, 2, 3, 4, 5, 6, 8, 12, 24, 36, 48, 60, 72, 96, 120h post-dose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.